Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Organogenesis (ORGO)

BGM Group Ltd. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. is the larger, with a market value of $125.7M against $108.1M — 1.2× the size. Organogenesis has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −43.5%) and the higher return on invested capital (0.00% vs −52.2%). Across the 16 metrics below, BGM Group Ltd. leads on 8 and Organogenesis on 8.

Valuation

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
P/E 148.17 n/m 20.55
P/S n/m 0.30 2.08
P/B n/m 0.89 1.79
Price to free cash flow n/m 30.18 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales (0.09) 0.27 2.87
Earnings yield 0.67% (145.78%) (15.94%)
Free cash flow yield 0.00% 3.31% 0.00%

Profitability

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 65.56% 53.51%
Operating margin 0.00% (24.45%) 0.00%
Net margin 1.96% (43.50%) (2.45%)
Free cash flow margin 0.00% 1.01% 0.00%
Return on equity 0.00% (81.71%) (0.80%)
Return on assets 0.00% (34.86%) (1.67%)
Return on invested capital 0.00% (52.15%) 0.00%

Growth

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (24.33%) 5.22%
EPS growth (last fiscal year) 10.00% 1,600.00% 42.91%
Revenue growth, 5-year CAGR (5.39%) 10.77% 7.24%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.09 0.04
Current ratio 1.25 3.32 2.41
Net debt to EBITDA 0.97 (1.14) 1.01

Dividend

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric BGM ORGO Drug Manufacturers Specialty & Generic median
Market cap 125.72m 108.08m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack